Chromosome 13 dementia syndromes as models of neurodegeneration

References

• Westermark P, Araki S, Benson M, Cohen A, Frangione B, Masters C, Saraiva M, Sipe J, Husby G, Kyle R, Selkoe D. Nomenclature of amyloid fibril proteins. Amyloid: Int J Exp Clin Invest 1999; 6: 62–66
   Google Scholar
• Huilgol S, Ramnrain N, Carrington P, Leigh I, Black M. Cytokeratins in primary cutaneous amyloidosis. Australas J Dermatol 1998; 39: 81–85
   PubMedGoogle Scholar
• Vidal R, Frangione B, Rostagno A, Mead S, Révész T, Plant G, Ghiso J. A stop-codon mutation in the BRI, gene associated with familial British dementia. Nature 1999; 399: 776–781
   PubMed Web of Science ®Google Scholar
• Häggqvist B, Näslund J, Sletten K, Westermark G, Mucchiano G, Tjernberg L, Nordstedt C, Engström U, Westermark P. Medin: An integral fragment of aortic smooth muscle cell-produced lactadherin forms the most common human amyloid. Proc Natl Acad Sci USA 1999; 96: 8669–8674
   PubMed Web of Science ®Google Scholar
• Vidal R, Révész T, Rostagno A, Kim E, Holton J, Bek T, Bojsen-Móller M, Braendgaard H, Plant G, Ghiso J, Frangione B. A decamer duplication in the 3′ region of the BRI, gene originates a new amyloid peptide that is associated with dementia in a Danish kindred. Proc Natl Acad Sci USA 2000; 97: 4920–4925
   PubMed Web of Science ®Google Scholar
• Schmitt-Bernard C F, Chavanieu A, Derancourt J, Arnaud B, Demaille J, Calas B, Argiles A. In vitro, creation of amyloid fibrils from native Arg124Cys mutated βGH3(110–131.) peptides, and its relevance for lattice corneal amyloid dystrophy type I. Biochem Biophys Res Commun 2000; 273: 649–653
   PubMedGoogle Scholar
• Pittois K, Deleersnijder W, Merregaert J. cDNA sequence analysis, chromosomal assignment and expression pattern of the gene coding for integral membrane protein 2B. Gene 1998; 217: 141–149
   Google Scholar
• Kim S H., Wang R, Gordon D J, Bass J, Steiner D, Lynn D G, Thinakaran G, Meredith S, Sisodia S S. Furin mediates enhanced production of fibrillogenic ABri peptides in familial British dementia. Nature Neurosc 1999; 2: 984–988
   PubMed Web of Science ®Google Scholar
• Mori H, Takio K, Ogawara M, Selkoe D. Mass spectrometry of purified amyloid beta protein in Alzheimer's disease. J Biol Chem 1992; 267: 17082–17086
   PubMed Web of Science ®Google Scholar
• Saido T, Yamao-Harigaya W, Iwatsubo T, Kawashima S. Amino- and carboxyl-terminal heterogeneity of betaamyloid peptides deposited in human brain. Neurosc Lett 1996; 13: 173–176
   Google Scholar
• Tekirian T, Saido T, Markesbery W, Russell M, Wekstein D, Patel E, Geddes J. N-terminal heterogeneity of parenchymal and cerebrovascular Aβ deposits. J Neuropathol Exp Neurol 1998; 57: 76–94
   Google Scholar
• Ghiso J, Vidal R, Rostagno A, Miravalle L, Holton J, Révész T, Plant G, Frangione B. Amyloidogenesis in Familial British Dementia Is Associated with a Genetic Defect on Chromosome 13. The Molecular Basis of Dementia, J Growdon, R Wurtman, S Corkin, R Nitsch. Annals of the New York Academy of Sciences, New York Academy of Sciences, New York 2000; 927: 84–92
   Google Scholar
• Worster-Drought C, Hill T, McMenemey W. Familial presenile dementia with spastic paralysis. J Neurol Psychopathol 1933; 14: 27–34
   Google Scholar
• Worster-Drought C, Greenfield J G, McMenemey W. A form of familial presenile dementia with spastic paralysis (including the pathological examination of a case). Brain 1940; 63: 237–254
   Google Scholar
• Griffiths R., Mortimer T, Oppenheimer D, Spalding J. Congophilic angiopathy of the brain: a clinical and pathological report on two siblings. J Neurol Neurosurg Psych 1982; 45: 396–408
   PubMedGoogle Scholar
• Love S, Duchen L. Familial cerebellar ataxia with cerebrovascular amyloid. J Neurol Neurosurg Psych 1982; 45: 271–273
   Google Scholar
• Plant G, Révész T, Barnard R, Harding A, Gautier-Smith P. Familial cerebral amyloid angiopathy with nonneuritic plaque formation. Brain 1990; 113: 721–747
   PubMedGoogle Scholar
• Mead S, James-Galton M, Révész T, Doshi R B, Harwood G, Pan E L, Ghiso J, Frangione B, Plant G. Familial British dementia with amyloid angiopathy: Early clinical, neuropsychological and imaging findings. Brain 2000; 123: 975–986
   Google Scholar
• Révész T, Holton J, Doshi B, Anderton B, Scaravilli F, Plant G. Cytoskeletal pathology in familial cerebral amyloid angiopathy (British type) with non-neuritic plaque formation. Acta Neuropath 1999; 97: 170–176
   PubMed Web of Science ®Google Scholar
• Holton J, Ghiso J, Lashley T, Rostagno A, Guerin C, Gibb G, Houlden H, Ayling H, Martinian L, Anderton B, Wood N, Vidal R, Plant G, Frangione B, Révész T. Regional distribution of fibrillar and non-fibrillar ABri deposition and its association with neurofibrillary degeneration in Familial British Dementia. Am J Pathol 2001; 158: 515–526
   PubMed Web of Science ®Google Scholar
• Stromgrem H. Heredopathia ophthalmo-otoencephalica. Handbook of Clinical Neurology, P J Vinken, G W Bruyn. North Holland Publishing Co., Amsterdam 1981; 42: 150–152
   Google Scholar
• Bek T. Ocular changes in heredo-oto-ophtalmo-encephalopathy. Bri J Ophtalmol 2000; 84: 1298–1302
   PubMed Web of Science ®Google Scholar
• Plant G, Esiri M M. Familial cerebral amyloid angiopathies. The Neuropathology of Dementia, M M Esiri, J H Morris. Cambridge University Press, Cambridge 1997; 260–276
   Google Scholar